These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 23575677)

  • 1. Titanium dioxide nanomaterials cause endothelial cell leakiness by disrupting the homophilic interaction of VE-cadherin.
    Setyawati MI; Tay CY; Chia SL; Goh SL; Fang W; Neo MJ; Chong HC; Tan SM; Loo SC; Ng KW; Xie JP; Ong CN; Tan NS; Leong DT
    Nat Commun; 2013; 4():1673. PubMed ID: 23575677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desacetylvinblastine Monohydrazide Disrupts Tumor Vessels by Promoting VE-cadherin Internalization.
    Lei X; Chen M; Huang M; Li X; Shi C; Zhang D; Luo L; Zhang Y; Ma N; Chen H; Liang H; Ye W; Zhang D
    Theranostics; 2018; 8(2):384-398. PubMed ID: 29290815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/β-catenin signaling.
    Pati S; Khakoo AY; Zhao J; Jimenez F; Gerber MH; Harting M; Redell JB; Grill R; Matsuo Y; Guha S; Cox CS; Reitz MS; Holcomb JB; Dash PK
    Stem Cells Dev; 2011 Jan; 20(1):89-101. PubMed ID: 20446815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p18, a novel adaptor protein, regulates pulmonary endothelial barrier function via enhanced endocytic recycling of VE-cadherin.
    Chichger H; Duong H; Braza J; Harrington EO
    FASEB J; 2015 Mar; 29(3):868-81. PubMed ID: 25404710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial cell Piezo1 mediates pressure-induced lung vascular hyperpermeability via disruption of adherens junctions.
    Friedrich EE; Hong Z; Xiong S; Zhong M; Di A; Rehman J; Komarova YA; Malik AB
    Proc Natl Acad Sci U S A; 2019 Jun; 116(26):12980-12985. PubMed ID: 31186359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rab5-mediated VE-cadherin internalization regulates the barrier function of the lung microvascular endothelium.
    Yang J; Yao W; Qian G; Wei Z; Wu G; Wang G
    Cell Mol Life Sci; 2015 Dec; 72(24):4849-66. PubMed ID: 26112597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressing PTEN activity by tobacco smoke plus interleukin-1beta modulates dissociation of VE-cadherin/beta-catenin complexes in endothelium.
    Barbieri SS; Ruggiero L; Tremoli E; Weksler BB
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):732-8. PubMed ID: 18202321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interference With ESAM (Endothelial Cell-Selective Adhesion Molecule) Plus Vascular Endothelial-Cadherin Causes Immediate Lethality and Lung-Specific Blood Coagulation.
    Duong CN; Nottebaum AF; Butz S; Volkery S; Zeuschner D; Stehling M; Vestweber D
    Arterioscler Thromb Vasc Biol; 2020 Feb; 40(2):378-393. PubMed ID: 31826650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of vascular endothelial-cadherin and beta-catenin localization by vascular endothelial growth factor-induced angiogenesis in human umbilical vein cells.
    Wright TJ; Leach L; Shaw PE; Jones P
    Exp Cell Res; 2002 Nov; 280(2):159-68. PubMed ID: 12413882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor signaling potentiates VE-cadherin stability at adherens junctions by regulating SHP2.
    Hatanaka K; Lanahan AA; Murakami M; Simons M
    PLoS One; 2012; 7(5):e37600. PubMed ID: 22629427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stealthy nanoparticles protect endothelial barrier from leakiness by resisting the absorption of VE-cadherin.
    Huang Y; Wang S; Zhang J; Wang H; Zou Q; Wu L
    Nanoscale; 2021 Aug; 13(29):12577-12586. PubMed ID: 34259298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
    Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ
    Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transference of recombinant VE-cadherin cytoplasmic domain alters endothelial junctional integrity and porcine microvascular permeability.
    Guo M; Wu MH; Granger HJ; Yuan SY
    J Physiol; 2004 Jan; 554(Pt 1):78-88. PubMed ID: 14678493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VE-cadherin status as an indicator of microvascular permeability.
    Monaghan-Benson E; Burridge K
    Methods Mol Biol; 2013; 1046():335-42. PubMed ID: 23868598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers.
    Adam AP; Sharenko AL; Pumiglia K; Vincent PA
    J Biol Chem; 2010 Mar; 285(10):7045-55. PubMed ID: 20048167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeability.
    Corada M; Zanetta L; Orsenigo F; Breviario F; Lampugnani MG; Bernasconi S; Liao F; Hicklin DJ; Bohlen P; Dejana E
    Blood; 2002 Aug; 100(3):905-11. PubMed ID: 12130501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cdc42 regulates adherens junction stability and endothelial permeability by inducing alpha-catenin interaction with the vascular endothelial cadherin complex.
    Broman MT; Kouklis P; Gao X; Ramchandran R; Neamu RF; Minshall RD; Malik AB
    Circ Res; 2006 Jan; 98(1):73-80. PubMed ID: 16322481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SHP2 protects endothelial cell barrier through suppressing VE-cadherin internalization regulated by MET-ARF1.
    Zhang J; Huang J; Qi T; Huang Y; Lu Y; Zhan T; Gong H; Zhu Z; Shi Y; Zhou J; Yu L; Zhang X; Cheng H; Ke Y
    FASEB J; 2019 Jan; 33(1):1124-1137. PubMed ID: 30102570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urocortin increased LPS-induced endothelial permeability by regulating the cadherin-catenin complex via corticotrophin-releasing hormone receptor 2.
    Wan R; Guo R; Chen C; Jin L; Zhu C; Zhang Q; Xu Y; Li S
    J Cell Physiol; 2013 Jun; 228(6):1295-303. PubMed ID: 23168683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. eNOS-derived nitric oxide regulates endothelial barrier function through VE-cadherin and Rho GTPases.
    Di Lorenzo A; Lin MI; Murata T; Landskroner-Eiger S; Schleicher M; Kothiya M; Iwakiri Y; Yu J; Huang PL; Sessa WC
    J Cell Sci; 2013 Dec; 126(Pt 24):5541-52. PubMed ID: 24046447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.